nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—CYP2C9—Vismodegib—skin cancer	0.145	0.236	CbGbCtD
Bexarotene—CYP3A4—Imiquimod—skin cancer	0.122	0.198	CbGbCtD
Bexarotene—CYP3A4—Temozolomide—skin cancer	0.122	0.198	CbGbCtD
Bexarotene—CYP3A4—Vismodegib—skin cancer	0.0845	0.137	CbGbCtD
Bexarotene—CYP3A4—Vemurafenib—skin cancer	0.0668	0.109	CbGbCtD
Bexarotene—CYP2C9—Fluorouracil—skin cancer	0.0516	0.0839	CbGbCtD
Bexarotene—CYP3A4—Docetaxel—skin cancer	0.0229	0.0373	CbGbCtD
Bexarotene—Migraine—Docetaxel—skin cancer	0.00046	0.00119	CcSEcCtD
Bexarotene—Abdominal pain—Imiquimod—skin cancer	0.000455	0.00118	CcSEcCtD
Bexarotene—Body temperature increased—Imiquimod—skin cancer	0.000455	0.00118	CcSEcCtD
Bexarotene—Eye disorder—Temozolomide—skin cancer	0.000454	0.00118	CcSEcCtD
Bexarotene—Tinnitus—Temozolomide—skin cancer	0.000453	0.00118	CcSEcCtD
Bexarotene—Malaise—Bleomycin—skin cancer	0.000452	0.00117	CcSEcCtD
Bexarotene—Cardiac disorder—Temozolomide—skin cancer	0.000451	0.00117	CcSEcCtD
Bexarotene—Haemoglobin—Fluorouracil—skin cancer	0.00045	0.00117	CcSEcCtD
Bexarotene—Leukopenia—Bleomycin—skin cancer	0.000449	0.00117	CcSEcCtD
Bexarotene—Rhinitis—Fluorouracil—skin cancer	0.000449	0.00117	CcSEcCtD
Bexarotene—Haemorrhage—Fluorouracil—skin cancer	0.000448	0.00116	CcSEcCtD
Bexarotene—Dizziness—Vemurafenib—skin cancer	0.000447	0.00116	CcSEcCtD
Bexarotene—Hypoaesthesia—Fluorouracil—skin cancer	0.000446	0.00116	CcSEcCtD
Bexarotene—Pharyngitis—Fluorouracil—skin cancer	0.000444	0.00115	CcSEcCtD
Bexarotene—Angiopathy—Temozolomide—skin cancer	0.000441	0.00115	CcSEcCtD
Bexarotene—Ataxia—Docetaxel—skin cancer	0.000439	0.00114	CcSEcCtD
Bexarotene—Cough—Bleomycin—skin cancer	0.000438	0.00114	CcSEcCtD
Bexarotene—Chills—Temozolomide—skin cancer	0.000436	0.00113	CcSEcCtD
Bexarotene—Dehydration—Docetaxel—skin cancer	0.000434	0.00113	CcSEcCtD
Bexarotene—Ill-defined disorder—Dactinomycin—skin cancer	0.000434	0.00113	CcSEcCtD
Bexarotene—Anaemia—Dactinomycin—skin cancer	0.000432	0.00112	CcSEcCtD
Bexarotene—Liver function test abnormal—Docetaxel—skin cancer	0.000431	0.00112	CcSEcCtD
Bexarotene—Vomiting—Vemurafenib—skin cancer	0.00043	0.00112	CcSEcCtD
Bexarotene—Alopecia—Temozolomide—skin cancer	0.000429	0.00112	CcSEcCtD
Bexarotene—Dry skin—Docetaxel—skin cancer	0.000428	0.00111	CcSEcCtD
Bexarotene—Chest pain—Bleomycin—skin cancer	0.000427	0.00111	CcSEcCtD
Bexarotene—Myalgia—Bleomycin—skin cancer	0.000427	0.00111	CcSEcCtD
Bexarotene—Rash—Vemurafenib—skin cancer	0.000426	0.00111	CcSEcCtD
Bexarotene—Dermatitis—Vemurafenib—skin cancer	0.000426	0.00111	CcSEcCtD
Bexarotene—Hypersensitivity—Imiquimod—skin cancer	0.000425	0.0011	CcSEcCtD
Bexarotene—Headache—Vemurafenib—skin cancer	0.000423	0.0011	CcSEcCtD
Bexarotene—Malnutrition—Temozolomide—skin cancer	0.000423	0.0011	CcSEcCtD
Bexarotene—Erythema—Temozolomide—skin cancer	0.000423	0.0011	CcSEcCtD
Bexarotene—Discomfort—Bleomycin—skin cancer	0.000422	0.0011	CcSEcCtD
Bexarotene—Malaise—Dactinomycin—skin cancer	0.000422	0.0011	CcSEcCtD
Bexarotene—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000421	0.00109	CcSEcCtD
Bexarotene—Leukopenia—Dactinomycin—skin cancer	0.000419	0.00109	CcSEcCtD
Bexarotene—Dysgeusia—Temozolomide—skin cancer	0.000414	0.00108	CcSEcCtD
Bexarotene—Asthenia—Imiquimod—skin cancer	0.000413	0.00107	CcSEcCtD
Bexarotene—Confusional state—Bleomycin—skin cancer	0.000413	0.00107	CcSEcCtD
Bexarotene—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000412	0.00107	CcSEcCtD
Bexarotene—Oedema—Bleomycin—skin cancer	0.000409	0.00106	CcSEcCtD
Bexarotene—Back pain—Temozolomide—skin cancer	0.000409	0.00106	CcSEcCtD
Bexarotene—Pruritus—Imiquimod—skin cancer	0.000408	0.00106	CcSEcCtD
Bexarotene—Infection—Bleomycin—skin cancer	0.000407	0.00106	CcSEcCtD
Bexarotene—Dysphagia—Docetaxel—skin cancer	0.000404	0.00105	CcSEcCtD
Bexarotene—Nausea—Vemurafenib—skin cancer	0.000401	0.00104	CcSEcCtD
Bexarotene—Thrombocytopenia—Bleomycin—skin cancer	0.000401	0.00104	CcSEcCtD
Bexarotene—Arrhythmia—Fluorouracil—skin cancer	0.0004	0.00104	CcSEcCtD
Bexarotene—Myalgia—Dactinomycin—skin cancer	0.000398	0.00103	CcSEcCtD
Bexarotene—Alopecia—Fluorouracil—skin cancer	0.000396	0.00103	CcSEcCtD
Bexarotene—Diarrhoea—Imiquimod—skin cancer	0.000394	0.00102	CcSEcCtD
Bexarotene—Discomfort—Dactinomycin—skin cancer	0.000393	0.00102	CcSEcCtD
Bexarotene—Angina pectoris—Docetaxel—skin cancer	0.000393	0.00102	CcSEcCtD
Bexarotene—Ill-defined disorder—Temozolomide—skin cancer	0.000393	0.00102	CcSEcCtD
Bexarotene—Anaemia—Temozolomide—skin cancer	0.000391	0.00102	CcSEcCtD
Bexarotene—Anorexia—Bleomycin—skin cancer	0.00039	0.00101	CcSEcCtD
Bexarotene—Erythema—Fluorouracil—skin cancer	0.00039	0.00101	CcSEcCtD
Bexarotene—Agitation—Temozolomide—skin cancer	0.000389	0.00101	CcSEcCtD
Bexarotene—Pancytopenia—Docetaxel—skin cancer	0.000383	0.000996	CcSEcCtD
Bexarotene—Oedema—Dactinomycin—skin cancer	0.000382	0.000992	CcSEcCtD
Bexarotene—Malaise—Temozolomide—skin cancer	0.000382	0.000991	CcSEcCtD
Bexarotene—Dizziness—Imiquimod—skin cancer	0.000381	0.00099	CcSEcCtD
Bexarotene—Vertigo—Temozolomide—skin cancer	0.00038	0.000987	CcSEcCtD
Bexarotene—Infection—Dactinomycin—skin cancer	0.000379	0.000985	CcSEcCtD
Bexarotene—Leukopenia—Temozolomide—skin cancer	0.000379	0.000984	CcSEcCtD
Bexarotene—Neutropenia—Docetaxel—skin cancer	0.000378	0.000981	CcSEcCtD
Bexarotene—Palpitations—Temozolomide—skin cancer	0.000374	0.000971	CcSEcCtD
Bexarotene—Thrombocytopenia—Dactinomycin—skin cancer	0.000374	0.000971	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000373	0.000969	CcSEcCtD
Bexarotene—Cough—Temozolomide—skin cancer	0.000369	0.000959	CcSEcCtD
Bexarotene—Paraesthesia—Bleomycin—skin cancer	0.000368	0.000955	CcSEcCtD
Bexarotene—Weight increased—Docetaxel—skin cancer	0.000367	0.000955	CcSEcCtD
Bexarotene—Vomiting—Imiquimod—skin cancer	0.000366	0.000952	CcSEcCtD
Bexarotene—Weight decreased—Docetaxel—skin cancer	0.000365	0.000949	CcSEcCtD
Bexarotene—Hypertension—Temozolomide—skin cancer	0.000365	0.000949	CcSEcCtD
Bexarotene—Dyspnoea—Bleomycin—skin cancer	0.000365	0.000948	CcSEcCtD
Bexarotene—Anorexia—Dactinomycin—skin cancer	0.000364	0.000945	CcSEcCtD
Bexarotene—Rash—Imiquimod—skin cancer	0.000363	0.000944	CcSEcCtD
Bexarotene—Dermatitis—Imiquimod—skin cancer	0.000363	0.000943	CcSEcCtD
Bexarotene—Pneumonia—Docetaxel—skin cancer	0.000362	0.000941	CcSEcCtD
Bexarotene—Headache—Imiquimod—skin cancer	0.000361	0.000938	CcSEcCtD
Bexarotene—Anaemia—Fluorouracil—skin cancer	0.00036	0.000936	CcSEcCtD
Bexarotene—Arthralgia—Temozolomide—skin cancer	0.00036	0.000936	CcSEcCtD
Bexarotene—Myalgia—Temozolomide—skin cancer	0.00036	0.000936	CcSEcCtD
Bexarotene—Anxiety—Temozolomide—skin cancer	0.000359	0.000932	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000358	0.000929	CcSEcCtD
Bexarotene—Discomfort—Temozolomide—skin cancer	0.000356	0.000924	CcSEcCtD
Bexarotene—Decreased appetite—Bleomycin—skin cancer	0.000356	0.000924	CcSEcCtD
Bexarotene—Neuropathy peripheral—Docetaxel—skin cancer	0.000353	0.000917	CcSEcCtD
Bexarotene—Dry mouth—Temozolomide—skin cancer	0.000352	0.000915	CcSEcCtD
Bexarotene—Jaundice—Docetaxel—skin cancer	0.000351	0.000912	CcSEcCtD
Bexarotene—Stomatitis—Docetaxel—skin cancer	0.000351	0.000912	CcSEcCtD
Bexarotene—Pain—Bleomycin—skin cancer	0.00035	0.000909	CcSEcCtD
Bexarotene—Conjunctivitis—Docetaxel—skin cancer	0.00035	0.000909	CcSEcCtD
Bexarotene—Leukopenia—Fluorouracil—skin cancer	0.000349	0.000906	CcSEcCtD
Bexarotene—Confusional state—Temozolomide—skin cancer	0.000348	0.000904	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000348	0.000903	CcSEcCtD
Bexarotene—Oedema—Temozolomide—skin cancer	0.000345	0.000897	CcSEcCtD
Bexarotene—Infection—Temozolomide—skin cancer	0.000343	0.000891	CcSEcCtD
Bexarotene—Nausea—Imiquimod—skin cancer	0.000342	0.000889	CcSEcCtD
Bexarotene—Epistaxis—Docetaxel—skin cancer	0.00034	0.000882	CcSEcCtD
Bexarotene—Nervous system disorder—Temozolomide—skin cancer	0.000339	0.00088	CcSEcCtD
Bexarotene—Thrombocytopenia—Temozolomide—skin cancer	0.000338	0.000878	CcSEcCtD
Bexarotene—Feeling abnormal—Bleomycin—skin cancer	0.000337	0.000876	CcSEcCtD
Bexarotene—Skin disorder—Temozolomide—skin cancer	0.000335	0.000871	CcSEcCtD
Bexarotene—Hyperhidrosis—Temozolomide—skin cancer	0.000334	0.000867	CcSEcCtD
Bexarotene—Chest pain—Fluorouracil—skin cancer	0.000332	0.000862	CcSEcCtD
Bexarotene—Myalgia—Fluorouracil—skin cancer	0.000332	0.000862	CcSEcCtD
Bexarotene—Decreased appetite—Dactinomycin—skin cancer	0.000332	0.000862	CcSEcCtD
Bexarotene—Fatigue—Dactinomycin—skin cancer	0.000329	0.000855	CcSEcCtD
Bexarotene—Anorexia—Temozolomide—skin cancer	0.000329	0.000855	CcSEcCtD
Bexarotene—Discomfort—Fluorouracil—skin cancer	0.000328	0.000852	CcSEcCtD
Bexarotene—Pain—Dactinomycin—skin cancer	0.000326	0.000848	CcSEcCtD
Bexarotene—Haemoglobin—Docetaxel—skin cancer	0.000325	0.000844	CcSEcCtD
Bexarotene—Rhinitis—Docetaxel—skin cancer	0.000324	0.000842	CcSEcCtD
Bexarotene—Body temperature increased—Bleomycin—skin cancer	0.000324	0.000841	CcSEcCtD
Bexarotene—Haemorrhage—Docetaxel—skin cancer	0.000323	0.00084	CcSEcCtD
Bexarotene—Hypoaesthesia—Docetaxel—skin cancer	0.000322	0.000835	CcSEcCtD
Bexarotene—Confusional state—Fluorouracil—skin cancer	0.000321	0.000833	CcSEcCtD
Bexarotene—Pharyngitis—Docetaxel—skin cancer	0.000321	0.000833	CcSEcCtD
Bexarotene—Urinary tract disorder—Docetaxel—skin cancer	0.000319	0.000829	CcSEcCtD
Bexarotene—Oedema peripheral—Docetaxel—skin cancer	0.000318	0.000827	CcSEcCtD
Bexarotene—Oedema—Fluorouracil—skin cancer	0.000318	0.000826	CcSEcCtD
Bexarotene—Connective tissue disorder—Docetaxel—skin cancer	0.000318	0.000825	CcSEcCtD
Bexarotene—Urethral disorder—Docetaxel—skin cancer	0.000317	0.000823	CcSEcCtD
Bexarotene—Infection—Fluorouracil—skin cancer	0.000316	0.000821	CcSEcCtD
Bexarotene—Feeling abnormal—Dactinomycin—skin cancer	0.000315	0.000817	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000315	0.000817	CcSEcCtD
Bexarotene—Insomnia—Temozolomide—skin cancer	0.000312	0.000811	CcSEcCtD
Bexarotene—Gastrointestinal pain—Dactinomycin—skin cancer	0.000312	0.000811	CcSEcCtD
Bexarotene—Nervous system disorder—Fluorouracil—skin cancer	0.000312	0.00081	CcSEcCtD
Bexarotene—Thrombocytopenia—Fluorouracil—skin cancer	0.000311	0.000809	CcSEcCtD
Bexarotene—Tachycardia—Fluorouracil—skin cancer	0.000311	0.000807	CcSEcCtD
Bexarotene—Paraesthesia—Temozolomide—skin cancer	0.00031	0.000805	CcSEcCtD
Bexarotene—Dyspnoea—Temozolomide—skin cancer	0.000308	0.0008	CcSEcCtD
Bexarotene—Somnolence—Temozolomide—skin cancer	0.000307	0.000797	CcSEcCtD
Bexarotene—Dyspepsia—Temozolomide—skin cancer	0.000304	0.00079	CcSEcCtD
Bexarotene—Anorexia—Fluorouracil—skin cancer	0.000303	0.000788	CcSEcCtD
Bexarotene—Eye disorder—Docetaxel—skin cancer	0.000302	0.000785	CcSEcCtD
Bexarotene—Abdominal pain—Dactinomycin—skin cancer	0.000302	0.000784	CcSEcCtD
Bexarotene—Body temperature increased—Dactinomycin—skin cancer	0.000302	0.000784	CcSEcCtD
Bexarotene—Hypersensitivity—Bleomycin—skin cancer	0.000302	0.000783	CcSEcCtD
Bexarotene—Decreased appetite—Temozolomide—skin cancer	0.0003	0.00078	CcSEcCtD
Bexarotene—Cardiac disorder—Docetaxel—skin cancer	0.0003	0.000779	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Temozolomide—skin cancer	0.000298	0.000774	CcSEcCtD
Bexarotene—Fatigue—Temozolomide—skin cancer	0.000298	0.000773	CcSEcCtD
Bexarotene—Pain—Temozolomide—skin cancer	0.000295	0.000767	CcSEcCtD
Bexarotene—Constipation—Temozolomide—skin cancer	0.000295	0.000767	CcSEcCtD
Bexarotene—Asthenia—Bleomycin—skin cancer	0.000294	0.000763	CcSEcCtD
Bexarotene—Angiopathy—Docetaxel—skin cancer	0.000293	0.000762	CcSEcCtD
Bexarotene—Chills—Docetaxel—skin cancer	0.00029	0.000753	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00029	0.000753	CcSEcCtD
Bexarotene—Pruritus—Bleomycin—skin cancer	0.00029	0.000752	CcSEcCtD
Bexarotene—Arrhythmia—Docetaxel—skin cancer	0.000289	0.00075	CcSEcCtD
Bexarotene—Insomnia—Fluorouracil—skin cancer	0.000288	0.000747	CcSEcCtD
Bexarotene—Paraesthesia—Fluorouracil—skin cancer	0.000286	0.000742	CcSEcCtD
Bexarotene—Alopecia—Docetaxel—skin cancer	0.000286	0.000742	CcSEcCtD
Bexarotene—Feeling abnormal—Temozolomide—skin cancer	0.000285	0.000739	CcSEcCtD
Bexarotene—Dyspnoea—Fluorouracil—skin cancer	0.000284	0.000737	CcSEcCtD
Bexarotene—Somnolence—Fluorouracil—skin cancer	0.000283	0.000735	CcSEcCtD
Bexarotene—Gastrointestinal pain—Temozolomide—skin cancer	0.000282	0.000733	CcSEcCtD
Bexarotene—Erythema—Docetaxel—skin cancer	0.000281	0.000731	CcSEcCtD
Bexarotene—Malnutrition—Docetaxel—skin cancer	0.000281	0.000731	CcSEcCtD
Bexarotene—Hypersensitivity—Dactinomycin—skin cancer	0.000281	0.000731	CcSEcCtD
Bexarotene—Dyspepsia—Fluorouracil—skin cancer	0.00028	0.000727	CcSEcCtD
Bexarotene—Decreased appetite—Fluorouracil—skin cancer	0.000277	0.000718	CcSEcCtD
Bexarotene—Dysgeusia—Docetaxel—skin cancer	0.000276	0.000716	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000275	0.000713	CcSEcCtD
Bexarotene—Asthenia—Dactinomycin—skin cancer	0.000274	0.000711	CcSEcCtD
Bexarotene—Body temperature increased—Temozolomide—skin cancer	0.000273	0.000709	CcSEcCtD
Bexarotene—Abdominal pain—Temozolomide—skin cancer	0.000273	0.000709	CcSEcCtD
Bexarotene—Back pain—Docetaxel—skin cancer	0.000272	0.000707	CcSEcCtD
Bexarotene—Pain—Fluorouracil—skin cancer	0.000272	0.000707	CcSEcCtD
Bexarotene—Muscle spasms—Docetaxel—skin cancer	0.000271	0.000703	CcSEcCtD
Bexarotene—Feeling abnormal—Fluorouracil—skin cancer	0.000262	0.000681	CcSEcCtD
Bexarotene—Diarrhoea—Dactinomycin—skin cancer	0.000261	0.000678	CcSEcCtD
Bexarotene—Vomiting—Bleomycin—skin cancer	0.00026	0.000676	CcSEcCtD
Bexarotene—Anaemia—Docetaxel—skin cancer	0.00026	0.000675	CcSEcCtD
Bexarotene—Rash—Bleomycin—skin cancer	0.000258	0.00067	CcSEcCtD
Bexarotene—Dermatitis—Bleomycin—skin cancer	0.000258	0.00067	CcSEcCtD
Bexarotene—Hypersensitivity—Temozolomide—skin cancer	0.000254	0.000661	CcSEcCtD
Bexarotene—Syncope—Docetaxel—skin cancer	0.000252	0.000655	CcSEcCtD
Bexarotene—Leukopenia—Docetaxel—skin cancer	0.000252	0.000654	CcSEcCtD
Bexarotene—Body temperature increased—Fluorouracil—skin cancer	0.000251	0.000653	CcSEcCtD
Bexarotene—Palpitations—Docetaxel—skin cancer	0.000249	0.000646	CcSEcCtD
Bexarotene—Asthenia—Temozolomide—skin cancer	0.000248	0.000644	CcSEcCtD
Bexarotene—Loss of consciousness—Docetaxel—skin cancer	0.000247	0.000642	CcSEcCtD
Bexarotene—Cough—Docetaxel—skin cancer	0.000246	0.000638	CcSEcCtD
Bexarotene—Pruritus—Temozolomide—skin cancer	0.000244	0.000635	CcSEcCtD
Bexarotene—Nausea—Bleomycin—skin cancer	0.000243	0.000632	CcSEcCtD
Bexarotene—Hypertension—Docetaxel—skin cancer	0.000243	0.000631	CcSEcCtD
Bexarotene—Vomiting—Dactinomycin—skin cancer	0.000243	0.000631	CcSEcCtD
Bexarotene—Rash—Dactinomycin—skin cancer	0.000241	0.000625	CcSEcCtD
Bexarotene—Myalgia—Docetaxel—skin cancer	0.00024	0.000622	CcSEcCtD
Bexarotene—Arthralgia—Docetaxel—skin cancer	0.00024	0.000622	CcSEcCtD
Bexarotene—Chest pain—Docetaxel—skin cancer	0.00024	0.000622	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000238	0.000618	CcSEcCtD
Bexarotene—Diarrhoea—Temozolomide—skin cancer	0.000236	0.000614	CcSEcCtD
Bexarotene—Hypersensitivity—Fluorouracil—skin cancer	0.000234	0.000609	CcSEcCtD
Bexarotene—Dry mouth—Docetaxel—skin cancer	0.000234	0.000609	CcSEcCtD
Bexarotene—Confusional state—Docetaxel—skin cancer	0.000232	0.000601	CcSEcCtD
Bexarotene—Oedema—Docetaxel—skin cancer	0.00023	0.000596	CcSEcCtD
Bexarotene—Dizziness—Temozolomide—skin cancer	0.000228	0.000593	CcSEcCtD
Bexarotene—Infection—Docetaxel—skin cancer	0.000228	0.000593	CcSEcCtD
Bexarotene—Nausea—Dactinomycin—skin cancer	0.000227	0.000589	CcSEcCtD
Bexarotene—Shock—Docetaxel—skin cancer	0.000226	0.000587	CcSEcCtD
Bexarotene—Nervous system disorder—Docetaxel—skin cancer	0.000225	0.000585	CcSEcCtD
Bexarotene—Pruritus—Fluorouracil—skin cancer	0.000225	0.000585	CcSEcCtD
Bexarotene—Thrombocytopenia—Docetaxel—skin cancer	0.000225	0.000584	CcSEcCtD
Bexarotene—Tachycardia—Docetaxel—skin cancer	0.000224	0.000582	CcSEcCtD
Bexarotene—Skin disorder—Docetaxel—skin cancer	0.000223	0.000579	CcSEcCtD
Bexarotene—Vomiting—Temozolomide—skin cancer	0.00022	0.00057	CcSEcCtD
Bexarotene—Anorexia—Docetaxel—skin cancer	0.000219	0.000569	CcSEcCtD
Bexarotene—Rash—Temozolomide—skin cancer	0.000218	0.000566	CcSEcCtD
Bexarotene—Diarrhoea—Fluorouracil—skin cancer	0.000218	0.000565	CcSEcCtD
Bexarotene—Dermatitis—Temozolomide—skin cancer	0.000218	0.000565	CcSEcCtD
Bexarotene—Headache—Temozolomide—skin cancer	0.000216	0.000562	CcSEcCtD
Bexarotene—Dizziness—Fluorouracil—skin cancer	0.00021	0.000546	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000209	0.000543	CcSEcCtD
Bexarotene—Insomnia—Docetaxel—skin cancer	0.000208	0.000539	CcSEcCtD
Bexarotene—Paraesthesia—Docetaxel—skin cancer	0.000206	0.000536	CcSEcCtD
Bexarotene—Nausea—Temozolomide—skin cancer	0.000205	0.000533	CcSEcCtD
Bexarotene—Dyspnoea—Docetaxel—skin cancer	0.000205	0.000532	CcSEcCtD
Bexarotene—Somnolence—Docetaxel—skin cancer	0.000204	0.00053	CcSEcCtD
Bexarotene—Vomiting—Fluorouracil—skin cancer	0.000202	0.000525	CcSEcCtD
Bexarotene—Dyspepsia—Docetaxel—skin cancer	0.000202	0.000525	CcSEcCtD
Bexarotene—Rash—Fluorouracil—skin cancer	0.000201	0.000521	CcSEcCtD
Bexarotene—Dermatitis—Fluorouracil—skin cancer	0.0002	0.000521	CcSEcCtD
Bexarotene—Decreased appetite—Docetaxel—skin cancer	0.0002	0.000519	CcSEcCtD
Bexarotene—Headache—Fluorouracil—skin cancer	0.000199	0.000518	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Docetaxel—skin cancer	0.000198	0.000515	CcSEcCtD
Bexarotene—Fatigue—Docetaxel—skin cancer	0.000198	0.000514	CcSEcCtD
Bexarotene—Pain—Docetaxel—skin cancer	0.000196	0.00051	CcSEcCtD
Bexarotene—Constipation—Docetaxel—skin cancer	0.000196	0.00051	CcSEcCtD
Bexarotene—Feeling abnormal—Docetaxel—skin cancer	0.000189	0.000492	CcSEcCtD
Bexarotene—Nausea—Fluorouracil—skin cancer	0.000189	0.000491	CcSEcCtD
Bexarotene—Gastrointestinal pain—Docetaxel—skin cancer	0.000188	0.000488	CcSEcCtD
Bexarotene—Abdominal pain—Docetaxel—skin cancer	0.000182	0.000472	CcSEcCtD
Bexarotene—Body temperature increased—Docetaxel—skin cancer	0.000182	0.000472	CcSEcCtD
Bexarotene—Hypersensitivity—Docetaxel—skin cancer	0.000169	0.000439	CcSEcCtD
Bexarotene—Asthenia—Docetaxel—skin cancer	0.000165	0.000428	CcSEcCtD
Bexarotene—Pruritus—Docetaxel—skin cancer	0.000162	0.000422	CcSEcCtD
Bexarotene—Diarrhoea—Docetaxel—skin cancer	0.000157	0.000408	CcSEcCtD
Bexarotene—Dizziness—Docetaxel—skin cancer	0.000152	0.000394	CcSEcCtD
Bexarotene—Vomiting—Docetaxel—skin cancer	0.000146	0.000379	CcSEcCtD
Bexarotene—Rash—Docetaxel—skin cancer	0.000145	0.000376	CcSEcCtD
Bexarotene—Dermatitis—Docetaxel—skin cancer	0.000145	0.000376	CcSEcCtD
Bexarotene—Headache—Docetaxel—skin cancer	0.000144	0.000374	CcSEcCtD
Bexarotene—Nausea—Docetaxel—skin cancer	0.000136	0.000354	CcSEcCtD
